Company
Headquarters: Fribourg, Switzerland
Employees: 3,803
CEO: Mr. Eric Frey
CHF1.37 Billion
CHF as of July 1, 2024
US$1.51 Billion
Company | Market Cap (USD) |
---|---|
Lilly | $808.65 B |
Novo Nordisk | $622.07 B |
UnitedHealth Group | $450.89 B |
Johnson & Johnson | $350.63 B |
Merck | $318.75 B |
Aevis Victoria SA engages in healthcare, hospitality, lifestyle, and infrastructure sectors in Switzerland. The company operates through Hospitals, Hospitality, Telemedicine, and Real Estate segments. It operates 22 hospitals with 1,496 beds; manages 9 luxury hotels with a total of 940 rooms and 306 suites; and a portfolio of 39 healthcare related real estate properties with a total rentable surface of 182,207 sqm, as well as 18 hotel related real estate properties with a total surface of 100,913 sqm. The company also provides telemedicine, and ambulance and day clinic services. In addition, it engages in the patient hotel, better aging, radiology institute, pharmacy, ophthalmology, real estate management, stem cells, cosmetics, and publishing businesses, as well as organizes seminars. The company was formerly known as AEVIS Holding SA and changed its name to Aevis Victoria SA in June 2015. The company is headquartered in Fribourg, Switzerland. Aevis Victoria SA is a subsidiary of M.R.S.I. Medical Research, Services and Investments S.A.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Aevis Victoria SA has the following listings and related stock indices.
Stock: SIX: AEVS wb_incandescent